SCL Science KRX:246960KOSDAQ
SCL사이언스 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days1
Articles tracked0since Sep 11
In Q2 2026, SCL Science reported revenue of ₩7.6bn, up 68.9% year on year, and operating profit of ₩406m. SCL Science (SCL사이언스) appeared in 0 Korean news articles and 1 DART filing over the past seven days.
Filing signals Turnaround Screener
SCL Science quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩7.6bn | +68.9% | ₩406m | −₩130m |
| Q1 2026 | ₩7.7bn | +237.9% | −₩648m | −₩994m |
| Q4 2025 derived | ₩8.3bn | +419.2% | −₩848m | −₩2.6bn |
| Q3 2025 | ₩7.0bn | +594.8% | ₩169m | −₩122m |
| Q2 2025 | ₩4.5bn | +347.1% | −₩1.4bn | ₩207m |
| Q1 2025 | ₩2.3bn | +100.0% | −₩1.3bn | −₩1.6bn |
| Q4 2024 derived | ₩1.6bn | +152.3% | −₩1.4bn | −₩1.3bn |
| Q3 2024 | ₩1.0bn | +248.7% | −₩780m | −₩822m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.
SCL Science top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest SCL Science news Korean headlines
No articles yet.